Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NAVAMEDIC ASA: REGISTRATION OF SHARE CAPITAL INCREASE

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE ANNOUNCEMENT. Reference is made to the stock exchange announcement from Navamedic ASA (the "Company") published on 12 June 2020 regarding the final result of the subsequent offering where 347,337 new shares (the "New

Telephone conference 17 July in connection with Interim report

The Interim report January-June 2020 will be released on Friday, 17 July around 07.00 CET.At 09.00 CET a telephone conference will be held, participant connection: UK: +44 33 3300 9030, SE: +46 8 505 583 50, US: 1 833 526 8382. The telephone conference will be webcasted live at www.ratos.se where presentation material will be available as soon as the report is released. The telephone conference will be recorded and available at www.ratos.se. For further information, please contact:Helene Gustafsson, Head of IR & Press, +46 8 700 17 98, helene.gustafsson@ratos.se About Ratos:

Invitation to presentation of results for Second quarter and half year results 2020

22 June 2020 – Kværner ASA will publish its Second quarter and half year results 2020 at the Oslo Stock Exchange on Thursday 9 July 2020 at 07:00 CET. Following that, a live presentation will be held at 09:00 CET the same morning, which is made available through a webcast and a dial-in conference call only. The presentation will be concluded with a Q&A session. The presentation will be web casted live, and available through a dial-in conference call. There will be a Q&A session following the presentation. The replay will be made available on the company’s website www.kvaerner.com.

Three prestigious assignments for Assemblin Norway

This spring, Assemblin Norway was entrusted with the task of assisting in the planning of heating and sanitation solutions in three exciting new partnering projects in Oslo. The assignment entails the possibility, in a later phase, of also performing installations estimated at a total value of approximately NOK 800 million, of which some NOK 130 million has already been contracted for the implementation phase.The new projects are all located in the Oslo area and will run for several years, some of them through 2026. · The new Storbylegevakta hospital project, in which Assemblin has

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release June 22, 2020, at 11:30 a.m. Nokian Tyres has received an announcement from BlackRock, Inc. on June 18, 2020, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement BlackRock, Inc.'s indirect holding in Nokian Tyres shares fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on June 17, 2020. The indirect shareholding of BlackRock, Inc. in Nokian Tyres has decreased to 6,829,924 shares, corresponding to 4.91% of Nokian Tyres’ shares and

BioStock: Scandion Oncology and 2cureX receive Eurostars grant

Antioestrogen drug resistance is a major obstacle in the treatment of breast cancer. Scandion Oncology’s drug candidate SCO-101 has the potential to counteract such resistance, and the challenge has brought the biotech company together with the Functional Precision Medicine expert 2cureX, whose IndiTreat test may help stratify patients based on SCO-101 sensitivity in a planned clinical trial. The two Danish biotechs have received a Eurostars grant of 800,000 EUR, shared with Erasmus University Medical Centre to perform additional preclinical studies and to set up and run the trial.Read the

SimCorp A/S – Share buyback program

Company Announcement no. 30/2020 On February 5, 2020 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 10.0m, to be executed during the period from February 5, 2020 to July 31, 2020. The following transactions have been executed under the program:          Date Number of shares

Company Announcement No. 54, 2020 – Debtor composition in Nordea Kredit (CK 92)

Monthly information on debtor composition in Nordea Kredit published in order to comply with the Transparency Directive's disclosure requirements.Nordea Kredit hereby publishes monthly data on debtor composition of all callable bond series. The information is subject to disclosure requirements in the Securities Trading Act § 27a section 1.The information is also published in the usual way via the Copenhagen Stock Exchange / OMX.  Nordea Kredit Realkreditaktieselskab  Bo Dam Klausen Phone : +45 55 47 31 42

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release June 22, 2020, at 11:10 a.m. Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act Nokian Tyres has received an announcement from Sprucegrove Investment Management on June 18, 2020, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement Sprucegrove Investment Management's direct holding in Nokian Tyres shares fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on June 17, 2020. The direct shareholding of

Valmet to supply automation and solids measurements to Oulu Waterworks’ wastewater treatment plant in Finland

Taskila wastewater treatment plant [Taskila wastewater treatment plant in the City of Oulu. The new sludge treatment plant will be located in the lawn area next to the yellow thickeners.] Taskila wastewater treatment plant in the City of Oulu. The new sludge treatment plant will be located in the lawn area next to the yellow thickeners. Valmet Oyj’s trade press release on June 22, 2020 at 11:00 a.m. EET Valmet will supply automation system extension and solids measurements to Oulu Waterworks’ Taskila wastewater treatment plant located in Oulu, Finland. With modern wastewater

Avensia and commercetools announce a strategic partnership to deliver next generation e-commerce solutions to retailers around the world

Avensia, a global expert company within the field of modern commerce, and commercetools, a global leader in next-generation commerce software, has entered a strategic partnership. The combined offering will provide retailers around the world with unique state-of-the-art e-commerce solutions with maximum flexibility and short time to value. Demands from retailers and modern consumers are constantly evolving and Avensia has seen rapid growth and a greatly increased demand for its integrated modern commerce offering over the years. Recent events have accelerated the digital

Globally competitive plant protein based foods from Finland

Press release VTT together with University of Helsinki is supporting the Finnish food industry to develop plant protein products for the international market. The goal is to develop healthy, appealing and sustainable plant-based animal protein alternatives.Climate change and limited natural resources are challenging food security for the growing population. The protein supply is in this respect the most critical. Soy and wheat-based products, such as tofu and seitan, still cover a significant portion of the market for plant protein products, but there is room for new products on the

The Swedish National Board of Housing, Building and Planning has chosen Ida Infront for a new system

STOCKHOLM, June 22, 2020 - Addnode Group's subsidiary, Ida Infront, has won the contract to deliver a new case and decision support system to the Swedish National Board of Housing, Building and Planning. The system is based on the proprietary case management product iipax case and on the e-service platform Abou from the sister company Sokigo. The business value for licensing, development work and support and maintenance for the first four years is estimated at approximately SEK 25 million.The IT company Ida Infront will deliver new system support for case and decision support for grants and

Allotment under long-term incentive program

Press release 2020-06-22The annual general meeting in Stillfront Group AB (publ) held on 14 May 2020 resolved to issue not more than 350,000 warrants of series 2020/2024. Each warrant entitles the holder to subscribe for one (1) new share in the company on the last banking day in any month that falls during the period 1 June 2023 to 31 May 2024 at a subscription price of SEK 785.49, which is equal to the average volume weighted share price for the company’s share on Nasdaq First North Premier Growth Market during the period from and including 29 April 2020 until and including 13 May 2020,

AfterPay: Consumers state that they have made fewer e-commerce purchases in June, slowing down overall growth rates since mid-March

AMSTERDAM, JUNE 22[nd] 2020 | Results from AfterPay Insights ’ most recent survey responses show that e-commerce purchase growth in The Netherlands, Germany and Norway reached a plateau in May , with similarly declining growth rates now developing in the first half of June. Is this dampening growth the result of societies opening up? AfterPay Insights’ research into consumers’ recent e-commerce behavior now contains responses from more than 19.000 consumers in The

Changes in Telia Company’s Group Executive Management

In preparation of a renewed Nordics and Baltics strategy, and following the announcement of its intended exit from Turkey, Telia Company today announces several changes to the Group Executive Management team.· Markus Messerer will be appointed SVP, Chief of Strategy, Innovation & Head of Global Business. Markus is today the CEO of Alltron AG, Swiss IT group Competec's B2B business, and brings profound experience in digital transformation and ICT. Before Competec he was Head of Corporate Strategy at Swisscom. Markus is an Austrian national. · Rachel Samrén will be appointed SVP, Chief

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation, Stock exchange release, 22 June 2020 at 9:45 am EESTNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä CorporationBlackRock, Inc. has informed Wärtsilä Corporation that it’s aggregate holding has crossed above the 5% disclosure limit on 18 June 2020. Total position of BlackRock, Inc. and its funds subject to the notification: % of % of shares Total of Total number of shares shares and voting both in % and voting rights of and

Follicum AB receives Notice of Allowance from the US Patent Office for the protection of the company's peptides developed for the treatment of diabetes and its related complications

Follicum AB ("Follicum") has received information that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance of the US patent application 16/666,960. The patent application covers the company's peptides and their use for treatment of diabetes and diabetes-associated complications.The application is directed to new peptides from the company's two peptide classes, and their use in the treatment of diabetes and its complications. Follicum has now received Notice of Allowance for this application. In short, a Notice of Allowance means that the patent office in

Inhalation Sciences signs new CRO contract worth 75 KEUR with returning global pharma client

(Stockholm, 22 June 2020) Inhalation Sciences (ISAB) has signed a new CRO (Contract Research) order worth 75 KEUR for a project using its in vitro lung simulation tool DissolvIt[®]. The contract is with a returning CRO client—a noted global pharma company. CEO Manoush Masarrat: “This new order from a returning client underlines the benefits DissolvIt[®] gives inhaled drug developers. The voluminous, precise data DissolvIt[® ]deliver are, quite simply, leading. It’s a world-class solution. This new order confirms it once again.”Contract Research has long been an essential part of ISAB’s

FINAL ASSAYS CONFIRM HIGH NICKEL SULPHIDE DISCOVERY AT CORCEL PROJECT

Eurobattery Minerals AB (Nordic Growth Market: "BAT"; “the Company”) a growth company in the mining and exploration industry with the vision to help Europe become self-sufficient in ethical battery minerals, today announces the final results for sulphide mineral tests at the nickel, cobalt, copper Castriz prospect in Galicia, northwest Spain. In the larger Corcel project, Castriz is one of three primary prospects together with Monte Mayor and Monte Castello. Key points: · Final assay results received from nickel sulphide (Ni•S) assays on mineralised samples from recent drilling at

Pomegranate Investment AB (publ) releases Financial Report for the period of 6 months ended April 30, 2020 and 12 months ended April 30, 2020

NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO ANY U.S. PERSONHighlight of the reporting period · The net asset value of the Company was EUR 118.2 mln as per April 30, 2020 corresponding to EUR 21.9 per share, compared with NAV per share of EUR 21.1 as per October 31, 2019. · Digikala achieved 137% growth in NMV in Iranian year 1398 and reached positive adjusted EBITDA for the year as well as achieved many performance records, including highest number of Monthly Active Users – 26 M and highest Daily Net Order – 160 thousand. · Iranian stock market reached new all-time highs,

CEO Renée Aguiar-Lucander exercises warrants and invests SEK 15.7m (appr. USD 1.7m) in Calliditas

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that its CEO Renée Aguiar-Lucander will exercise warrants granted pursuant to Calliditas’ Warrant Program 2017/2020, which corresponds to an investment totaling SEK 15.7 million. Following the exercise, Ms. Aguiar-Lucander’s total shareholding in Calliditas corresponds to 412,000 shares.For further information, please contact: Renée Aguiar-Lucander, CEO, Calliditas Email: renee.lucander@calliditas.com Telephone: +46 722 52 10 06 Mikael Widell, Head of Communications Email: mikael.widell@calliditas.com

There are no items matching the current filter
There are no more items matching the current filter
Back to top